|Dr. David A. Newcomer||Chief Financial Officer||123.78k||N/A||1961|
|Dr. Marisa St. Claire DVM||VP - Primate Biology and Medicine||103k||N/A||1965|
|Dr. Mark G. Lewis||Chairman, CEO & Pres||N/A||N/A||1955|
|Mitch Franklin||Chief Operating Officer||N/A||N/A||N/A|
|Nancy A. Madden||VP of Admin. Operations & Biosafety Officer||N/A||N/A||N/A|
Bioqual, Inc. provides research, development, pre-clinical, consulting, and testing/assay services to commercial clients and government laboratories in the United States. The company provides research services in the areas of cancer, AIDS, hepatitis, influenza, immunology, transgenic, contraception, breeding and development of genetically defined animals, and neurobiology and behavior, as well as zika, dengue, malaria, respiratory syncytial virus, and other infectious diseases. Its services also include sample processing, virus stock generation, infectious virus quantitation, virus neutralization assays, hemagglutination inhibition assays, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides in-vivo animal model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Bioqual, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.